PULSAR Combined With Immunotherapy and Chemotherapy

Clinical trial NCT07291947 · RECRUITING

Trial details

NCT number: NCT07291947
Sponsor: Wang Xin
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2025-11-04
Primary completion: 2026-09-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.